龙星化工(002442) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥1,119,497,520.31, an increase of 11.58% compared to ¥1,003,283,827.33 in the same period last year[5] - Net profit attributable to shareholders was ¥12,736,621.40, reflecting an increase of 11.62% from ¥11,410,306.31 year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥12,391,024.64, up 40.06% from ¥8,846,989.57 in the previous year[5] - Total operating revenue for Q1 2023 was CNY 1,119,497,520.31, an increase of 11.6% compared to CNY 1,003,283,827.33 in Q1 2022[20] - Net profit for Q1 2023 reached CNY 12,736,621.40, representing a 11.6% increase from CNY 11,410,306.31 in Q1 2022[21] - The total comprehensive income for the first quarter of 2023 was CNY 12,735,378.78, an increase from CNY 11,408,695.17 in the same period last year, representing a growth of approximately 11.6%[22] - Basic and diluted earnings per share for the first quarter were both CNY 0.0263, up from CNY 0.0238 in the previous year, indicating an increase of about 2.1%[22] Cash Flow and Liquidity - The net cash flow from operating activities was -¥167,183,229.11, a decrease of 240.52% compared to ¥118,973,869.13 in the same period last year[5] - Cash inflow from operating activities was CNY 699,365,179.79, compared to CNY 593,377,591.10 in the previous year, reflecting a growth of approximately 17.8%[23] - Cash outflow from operating activities totaled CNY 866,548,408.90, significantly higher than CNY 474,403,721.97 in the same period last year, resulting in a net cash flow from operating activities of CNY -167,183,229.11[24] - Cash flow from investing activities showed a net outflow of CNY -10,682,961.00, an improvement from CNY -14,493,658.65 in the previous year[24] - Cash flow from financing activities generated a net inflow of CNY 157,942,035.98, compared to a net outflow of CNY -96,685,080.20 in the same period last year[24] - The ending balance of cash and cash equivalents was CNY 168,990,952.30, up from CNY 71,702,352.04 at the end of the previous year[24] - Cash and cash equivalents net increase decreased by 355.67% compared to the previous period, mainly due to a significant reduction in cash flow from operating activities[12] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,536,928,303.62, an increase of 4.64% from ¥3,379,986,412.58 at the end of the previous year[5] - Current liabilities increased to CNY 1,701,295,211.11 in Q1 2023, up from CNY 1,608,060,974.27 in Q1 2022, reflecting a growth of 5.8%[18] - The company's total liabilities reached CNY 1,928,753,401.83, an increase of 7.7% from CNY 1,791,102,206.44 in Q1 2022[18] - Long-term borrowings increased to CNY 221,447,815.77 in Q1 2023, compared to CNY 176,435,632.17 in Q1 2022, marking a rise of 25.5%[18] - The equity attributable to shareholders of the parent company was CNY 1,608,174,901.79, up from CNY 1,588,884,206.14 in Q1 2022, reflecting a growth of 1.2%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 37,697[12] - The largest shareholder, Liu Jiangshan, holds 19.95% of the shares, totaling 97,897,902 shares[12] - The number of shares held by the top ten shareholders includes significant stakes from Liu Jiangshan and Bohai International Trust, accounting for 34.75% of total shares[12] - The company has not identified any related party transactions among the top ten shareholders, except for known relationships[13] Operational Insights - Accounts receivable financing increased by 43.57% to ¥511,327,452.98, primarily due to an increase in received notes[8][9] - Prepayments increased by 35.01% to ¥52,584,933.86, mainly due to increased advance payments for raw material purchases[9] - Other current assets decreased by 66.35% to ¥7,145,915.98, primarily due to a reduction in deductible input tax[9] - The company reported a significant increase in credit impairment losses of 158.56%, amounting to -¥1,228,888.31, due to increased impairment provisions[10] - The company experienced a 102.46% increase in cash paid for goods and services, totaling ¥762,739,892.74, attributed to higher cash purchases[10] - Research and development expenses for Q1 2023 were CNY 6,467,685.11, a decrease of 21.8% from CNY 8,280,020.24 in Q1 2022[21] Regulatory and Compliance - The company received an administrative regulatory measure from the China Securities Regulatory Commission due to failure to identify related party transactions[14]